The pharmacy benefit manager has removed reauthorization requirements for more than 140 drugs so far this year amid what ...

UnitedHealth stock outlook is in sharp focus as shares stay locked between $300 and $310. With Q2 earnings approaching and ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately 116,000 to 118,000 adults.

Primary care clinicians focus on acute migraine management, despite the chronic nature of this neurological disease.

The real-world evidence solutions market is largely driven by the increasing prevalence of chronic diseases and their impact on real-world healthcare ...

UnitedHealth Group (UNH) is back in the spotlight — and for now, it’s for the right reasons. After one of the most bruising ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Shares of Centene have tumbled more than 20% after the healthcare giant stunned investors by withdrawing its full-year ...

UnitedHealth's shares drop 40% in 2025 amid challenges, with mixed Q1 earnings and margin pressures ahead. Read why I rate ...

The company is adding new products treating a range of issues, including HIV, hypertension and behavioral health.

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...